However, other genes regulation involved in anti-tumor immune response and resistance to immunotherapies, NECTIN4, HMGB1, TNFSF18, by CaPa or CaGe seem to be dependent on the cell line used and thus to be more heterogeneous. This evidence concerns the gene NECTIN4 and episodic ataxia type 2.